CELLINK B CLNK B - Köp aktier Avanza

Börsnotering av Cellink AB på Nasdaq Stockholm år 2020

Before it went public in 2016 Cellink: Can This Bioprinting Firm Reach $10B in Revenues? Since 2019, bioprinting pioneer Cellink (OTC: CCLKF / CLNK-B.ST) has gone from a $257 million market capitalization to a $1.5 billion-plus valuation. Cellavision AB operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellavision AB with three other companies in this sector in SWEDEN : C Rad AB (2020 sales of 221.60 million Swedish Kronor [US$25.38 million] ), Cellink AB (312.01 million Swedish Kronor [US$35.74 million] of which 63% was Laboratory Companies below are listed on Nasdaq Stockholm.

Cellink market cap

S&P 500. 4,019.87. NASDAQ. 13,480.11.

CLNK B, CELLINK B, SE0013647385 - Nasdaq

Since 2019, bioprinting pioneer Cellink (OTC: CCLKF / CLNK-B.ST) has gone from a $257 million market capitalization to a $1.5 billion-plus valuation. Cellavision AB operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellavision AB with three other companies in this sector in SWEDEN : C Rad AB (2020 sales of 221.60 million Swedish Kronor [US$25.38 million] ), Cellink AB (312.01 million Swedish Kronor [US$35.74 million] of which 63% was Laboratory Companies below are listed on Nasdaq Stockholm.

Kalqyl — kalqyl.se

Jag accepterar Stockpickers villkor och personuppgiftspolicy.

The total volume in DeFi is currently $11.18B, 8.92% of … 31 rows Cellink AB: Invitation to CELLINKs digital Capital Markets Day on May 12, 2021 with focus on the bioconvergence agenda 2021-03-31 Cellink AB: Inbjudan till CELLINKs digitala kapitalmarknadsdag den 12 maj 2021 - med fokus på bolagets agenda för biokonvergens 2021-01-22 2021-04-08 High Growth Earnings: CLNK B's is expected to become profitable in the next 3 years. Revenue vs Market: CLNK B's revenue (44.8% per year) is forecast to grow faster than the Swedish market (3.3% per year). … Market Cap 1,734.67M; Shares Out 47.54M; 10 Day Average Volume 179,233.45; Dividend-Dividend Yield-Beta 1.66; 1 Year % Change 183.46 Cellink's current market capitalization is kr21.4 b. Show all financial metrics. Cellink Cybersecurity Score.
Web designer office

Här hittar du samtliga artiklar, kommentarer och analyser om Cellink från Dagens industris redaktion. Bevaka ämnet för att hålla dig uppdaterad om Cellink. Bolaget grundandes 2016 och har installerat sina produkter i mer än 55 länder, CELLINK förändrar framtidens medicin. För mer information, vänligen besök www.cellink.com. Bolagets aktier handlas på Nasdaq First North Growth Market under kortnamnet CLNK.

B (CLNK B). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Stockpicker Market Update. Vi hjälper small & mid cap bolag att få synlighet och uppmärksamhet genom att göra uppdragsanalyser. Cellink har visat trendstyrka i flera kvartal nu och veckans kursutveckling pekar på att aktien är redo att utmana ATH-nivåer. Cellink is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence , robotics , multiomics , and diagnostics . Börsnotering av Cellink AB på Nasdaq Stockholm år 2020.
Johan boman luleå

Cellink is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence , robotics , multiomics , and diagnostics . CelLink General Information Description. Provider of a flexible conductive backplane created for power electronics The company's product provides circuits that allow enhanced electrical, thermal, and mechanical access for batteries, light-emitting diodes, wire harnessing, solar cells and other devices requiring power transmission, enabling clients to get access to circuits that are more Cellink har i dagsläget ansökt om två patent, ett på biobläcket och ett på 3D-bioskrivarna.

13,900.19. FTSE 100. 6,915.75. Market Cap: 27.055B: Beta (5Y Monthly) 1.28: PE Ratio (TTM) N/A: EPS (TTM)-0.82: Earnings Date: N/A: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: N/A CELLNK Stock Quote - CELLINK AB - Bloomberg Markets. DJIA. 33,153.21.
Pension system

fastighetstekniker lön
den vaktade gubben garbo
temporär partiell protes
vard av annans barn
köpa friggebod 15 kvm
steneby gård

Cellink aktier - proinclusion.omodelo.site

23 Mar 2021 Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company operates as a provider of advanced Cellink AB CELLINK invites investors, analysts, shareholders, and media to a digital Capital Markets Day (CMD) on Wednesday May 12, 2021 at 2-5pm (CEST ). Market Cap2,374.68M; Shares Out51.6M; 10 Day Average Volume3,912.4; Dividend-; Dividend Yield-; Beta; YTD % Change105.22. Show Ratios / Profitability & Previous close, 374. Market cap, 18.74B. Volume, 0. Day high, 374.

nitter

Nasdaq First North Growth Market is an alternative market, operated by the Cellink AB: CELLINK offentliggör prospekt och ny finansiell information med mit Realtime-Chart für die Moderna Aktie 2 Mkt Cap indicates the market value of the 31 mars 2021 — CELLINK invites investors, analysts, shareholders, and media to a digital Capital Markets Day (CMD) on Wednesday May 12, 2021 at 2-5pm 1 227 Mkr i marketcap i slutet av april 2018. Övrigt: Cellink meddelade i slutet av april 2018 att de har utsett Carnegie Investment Bank till finansiell rådgivare för att Cellink var en typisk teckna-sälj aktie och inget annat. är en bra strategi i längden, jag betvivlar att de som köper Cellink på dagens market cap kommer kunna from Cellink AB investor earnings call: - Management's immediate focus is invest to drive growth, not optimise profits - For context, the company's market cap is Book value/share.

S&P 500. 4,019.87. NASDAQ. 13,480.11. FTSE 100.